AVXL
AVXL
NASDAQ · Biotechnology

Anavex Life Sciences Corp

Penny Stocks Biotech Stocks Healthcare Stocks
$3.20
+0.08 (+2.56%)
As of May 9, 1:52 AM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +832.8% upside
Low Target $17.55
Average Target $29.85
High Target $40.51
Current Price $3.20
Current
$3.20
Target
$29.85
$17.55 $29.85 avg $40.51
Scenario Analysis
Bear Case
$17.55
448.4%
Low target
Base Case
$29.85
+832.8%
Avg target
Bull Case
$40.51
+1,165.9%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$13.99
-77.1% from high
52-Week Low
$2.61
+22.6% from low
Target vs 52W High
$29.85
+113.4% vs high
Next Earnings Report
May 11, 2026
Today
EPS Est: $-0.08
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%